help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchetti, B.
Right arrow Articles by Scapagnini, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchetti, B.
Right arrow Articles by Scapagnini, U.

Endocrinology, Vol 125, 1025-1036, Copyright © 1989 by Endocrine Society


ARTICLES

Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function

B Marchetti, V Guarcello, MC Morale, G Bartoloni, Z Farinella, S Cordaro and U Scapagnini
Department of Pharmacology, Medical School, University of Catania, Italy.

The present study was designed to explore the effects of LHRH and its agonists on immune system function. As a first step, to identify a putative site of action, the very potent and stable LHRH agonist (LHRH- A), [D-Ser(TBU6)] des-Gly10-LHRH ethylamide (buserelin), was used as an iodinated ligand to characterize LHRH receptors in a membrane preparation of rat thymus, a key organ of the immune system. The effects of LHRH and LHRH-A were then investigated on the proliferative capacity of rat thymocytes exposed in vitro to a mitogen and on ornithine decarboxylase specific activity. In addition, to determine whether LHRH-A treatment in vivo might directly influence thymic function, we treated hypophysectomized (hypox) rats with a moderately high dose of LHRH-A for a period of 2 weeks, and thymocyte mitogenic capacity, thymus weight, and the histological and functional appearance of the thymus were then assessed. Specific binding of LHRH-A to rat thymic membrane preparations is a saturable process, depending on both time and temperature of incubation, but differs markedly from binding to the rat pituitary or ovarian LHRH receptor in its low binding affinity. Binding is optimal in the absence of chelating agents (EDTA) or divalent metal ions, and increases linearly with increasing protein concentration. Binding is specific for LHRH, LHRH-A, and antagonists. Both the C-terminal amide and N-terminal regions of the LHRH molecule were required for binding, and amino acid substitutions at position 6 markedly enhanced and at position 8 markedly reduced binding potencies in rat thymic tissue. A number of peptides, proteins, and other agents had no effect on the specific binding of LHRH-A to thymic membrane preparations. The binding affinity (Ka) of the membrane receptor of the rat thymus for the LHRH superagonist buserelin was 8.4 x 10(8) M-1, while a higher binding affinity (Ka = 2.8 x 10(9) M-1) was calculated for the ovarian LHRH-binding site. Preincubation of rat thymocytes with LHRH-A for 20 h induced a significant dose-dependent increase in the proliferative response to the mitogen Concanavalin-A, monitored by [3H]thymidine incorporation. Using native LHRH, it was also possible to elicit stimulatory effects on the same parameter, although much higher concentrations were required than with LHRH-A. Furthermore, simultaneous addition of a LHRH antagonist, abolished the LHRH effect on thymocytes. Ornithine decarboxylase specific activity under lectin stimulation was also significantly increased by LHRH-A in cultures of rat thymocytes.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Integr. Comp. Biol.Home page
B. Lutton and I. Callard
Evolution of reproductive-immune interactions
Integr. Comp. Biol., December 1, 2006; 46(6): 1060 - 1071.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Enomoto, M. Utsumi, and M. K. Park
Gonadotropin-Releasing Hormone Induces Actin Cytoskeleton Remodeling and Affects Cell Migration in a Cell-Type-Specific Manner in TSU-Pr1 and DU145 Cells
Endocrinology, January 1, 2006; 147(1): 530 - 542.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. S. Sutherland, G. L. Goldberg, M. V. Hammett, A. P. Uldrich, S. P. Berzins, T. S. Heng, B. R. Blazar, J. L. Millar, M. A. Malin, A. P. Chidgey, et al.
Activation of Thymic Regeneration in Mice and Humans following Androgen Blockade
J. Immunol., August 15, 2005; 175(4): 2741 - 2753.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
B. MARCHETTI, F. GALLO, Z. FARINELLA, C. TIROLO, N. TESTA, S. CANIGLIA, and M. C. MORALE
Gender, Neuroendocrine-Immune Interactions and Neuron-Glial Plasticity: Role of Luteinizing Hormone-Releasing Hormone (LHRH)
Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 678 - 709.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H.-F. Chen, E.-B. Jeung, M. Stephenson, and P. C. K. Leung
Human Peripheral Blood Mononuclear Cells Express Gonadotropin-Releasing Hormone (GnRH), GnRH Receptor, and Interleukin-2 Receptor {gamma}-Chain Messenger Ribonucleic Acids That Are Regulated by GnRH in Vitro
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 743 - 750.
[Abstract] [Full Text]


Home page
Ann. N. Y. Acad. Sci.Home page
B. MARCHETTI, F. GALLO, Z. FARINELLA, C. TIROLO, N. TESTA, C. ROMEO, and M. C. MORALE
Luteinizing Hormone-Releasing Hormone Is a Primary Signaling Molecule in the Neuroimmune Network
Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 205 - 248.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society